Sponsor
Onward Therapeutics France
77 Rue De Vaugirard, 75006 Paris, France
About the sponsor
Research activity is centered on relapsed/refractory hematological malignancies, with attention to cancers that have returned after prior treatment or no longer respond adequately to standard care. This includes disease areas where new oncology approaches are needed for patients with limited treatment options.
- Relapsed disease
- Refractory cancer
- Hematologic oncology
The sponsor’s clinical interest in this field reflects a focus on difficult-to-treat blood cancers and the search for new therapeutic options in cancer treatment.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.